Proprio Doubles Down on Progress in Artificial Intelligence through Data Team Expansion


Innovative medical technology company hires new VP of Data Applications as it goes all in on AI development to fundamentally improve patient care.

Proprio, a Seattle-based medical technology company, is reaffirming its focus on artificial intelligence (AI) with a strategic expansion of its AI and data team. Recognizing the dynamic landscape of AI, especially in healthcare, Proprio is actively developing advanced applications of the technology to improve surgery and outcomes.

As part of this investment, Proprio announces the appointment of Kabir Gulati as the Vice President of Data Applications. With over 14 years of healthcare data experience, Gulati brings his knowledge of software design and computer vision, and a deep understanding of clinical workflows, to his new role. At Proprio, he will spearhead the development and implementation of the platform’s software applications to improve surgical guidance through data-driven solutions. 

"I am thrilled for the opportunity to contribute to an area of AI that is evolving by the minute and is so critical to our healthcare,” said Gulati. “At Proprio, there is a unique opportunity to actively address emerging challenges and contribute to the development of truly innovative solutions. It's incredibly rewarding to join such an accomplished and inventive team to drive progress in AI technology, particularly in the context of surgery, where there is such potential for positive impact.”

By harnessing the power of AI, Proprio’s flagship surgical guidance system, Paradigm™, not only streamlines complex clinical processes, drives operational efficiencies, and enhances patient outcomes, but is also specifically designed to accommodate the dynamic nature of surgery. By effectively capturing critical intraoperative data and fostering active collaboration with surgeons, Paradigm is poised to revolutionize surgical procedures across diverse specialties, advancing not only spine surgery but other fields as well.

“At Proprio, we have been at the forefront of AI in surgery since the company’s inception eight years ago. With Kabir’s arrival, we are even better positioned to give clinicians and patients technology that truly matters,” said Gabriel Jones, CEO and Co-founder of Proprio. “By continually pushing the bounds of AI development, we are maximizing the benefits of data-driven intelligence as we continue to shape the future of surgery.”

Proprio's Paradigm™ is FDA 510(k) cleared and is deployed in select leading hospitals across the US. For more information, visit